| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 80 | ₹6,000 |
| HNI / NII | 34 | 2,720 | ₹2,04,000 |
| bHNI / bNII | 167 | 13,360 | ₹10,02,000 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 1,30,83,333 (49.06%) | — | ₹11,120.83 Cr |
| NII / HNI (Total) | — | 39,25,000 (14.72%) | — | ₹3,336.25 Cr |
| Retail Investors | — | 91,58,334 (34.34%) | — | ₹7,784.58 Cr |
| Employee | — | 5,00,000 (1.87%) | — | ₹42.50 Cr |
| Total ** | — | 2,66,66,667 (100.00%) | — | ₹226,666.67 Cr |
| Metric | 30-Sept-09 | 31-Mar-09 | 31-Mar-08 |
|---|---|---|---|
| Revenue | 233.43 | 396.94 | 273.94 |
| PAT | 12.41 | 21.09 | 29.67 |
| EBITDA | — | — | — |
| Net Worth | — | — | — |
| Total Assets | — | — | — |
| Reserves | — | — | — |
| Borrowings | — | — | — |
Incorporated in 1996, Parabolic Drugs Limited is in the business of manufacturing Active Pharmaceutical Ingredients (API's) and API intermediates. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.
Companies product portfolio comprises 42 APIs and 7 API intermediates which are marketed domestically and exported.
Company own and operate two manufacturing facilities at Derabassi, Punjab, and Panchkula, Haryana. Company is in the process of setting up a custom synthesis and research and development (R&D) center at Barwala, Haryana.